Researchers are experimenting on a treatment for rare eye cancer, which has already saved some children from vision loss. The US researchers also succeeded in restoring vision in a few cases. The method involved inserting a catheter in the eye via the body so that the chemotherapy drug melphalan, made by GlaxoSmithKline under the name of Alkeran, was administered directly to the tumour.